A sales and marketing services company, which serves the biopharmaceutical and life sciences industries.
The best Bull and Bear pitches based on recency and number of recommendations.
Trading below book value, new management. Their price was beaten down for loss of a large contract, but they've since picked up another. Not profitable at the moment, but with the company trading below book value your risks are pretty low. With the… More
Read the most recent pitches from players about IDXG.
Recs
A Value Proposition
Recs
Trading below book value, new management. Their price was beaten down for loss of a large contract, but they've since picked up another. Not profitable at the moment, but with the company trading below book value your risks are pretty low. With the new sales director this stock can only get better.
Recs
Provides outsourced sales & marketing force capability for Pharma companies, that can either replace or augment an in-house sales force. Currently beaten down by the loss of 3 major accounts as of Dec 06 (GSK, SNY, Astra-Zeneca) accounting for $126M (56%) of revenues. Forward EPS -1.46 for '07 and negative again for '08. President of Sales just "resigned" in 4/07, and a somewhat nebulous "long-term strategic plan" will be implemented in 2007. Major selling point on this stock is that as of 4/07 it's trading below book value (P/B 0.88) giving potentially a margin of safety. But who knows, turnarounds can work. So I'll give it a short-term thumbs down, but may offer a good value opportunity for a risk-tolerant LT buy-and-hold portfolio.
Find the members with the highest scoring picks in IDXG.
drakitin (98.51) Score: +413.34
The Score Leader is the player with the highest score across all their picks in IDXG.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
drakitin | 98.51 | 8/19/2008 | 3Y | $76.10 | -98.03% | +315.32% | +413.34 | 0 Comment | ||
chicagobears | 86.37 | 3/13/2008 | 5Y | $85.00 | -98.24% | +312.61% | +410.85 | 0 Comment | ||
TMFNosediveflip | 82.97 | 9/27/2006 | 1Y | $110.40 | -98.64% | +308.02% | +406.66 | 0 Comment | ||
rgonzo310 | 88.46 | 3/19/2008 | 1Y | $82.20 | -98.18% | +305.86% | +404.03 | 0 Comment | ||
BenBernanke | 63.35 | 12/15/2006 | 3M | $105.30 | -98.58% | +280.89% | +379.47 | 0 Comment | ||
NuvoRiche | 76.08 | 4/17/2007 | 1Y | $95.00 | -98.42% | +268.74% | +367.17 | 1 Comment | ||
UFShowboat | < 20 | 4/23/2007 | NS | $94.00 | -98.40% | +265.43% | +363.84 | 0 Comment | ||
JoeySolitro3 | 99.24 | 12/19/2016 | 5Y | $9.30 | -83.87% | +127.14% | +211.01 | 0 Comment | ||
FriarPio | 58.20 | 3/22/2017 | 5Y | $2.84 | -47.18% | +119.46% | +166.64 | 0 Comment | ||
jed71 | 42.72 | 9/11/2017 | 5Y | $1.68 | -10.66% | +106.08% | +116.74 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.